We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Chip Identifies Toxicity as a Biological Quality

By LabMedica International staff writers
Posted on 30 Jul 2012
A biosensor detects toxicity quickly and accurately, generating low false positive and false negative readings.

Called the Dip Chip, the device contains microbes designed to exhibit a biological reaction to toxic chemicals, emulating the biological responses of humans or animals.

Invented by Prof. More...
Yosi Shacham-Diamand, vice dean of Tel Aviv University's Faculty of Engineering (Ramat Aviv, Israel) together with Prof. Shimshon Belkin of the Institute of Life Sciences at the Hebrew University of Jerusalem (Givat Ram, Jerusalem, Israel), the device contains microbes designed to exhibit a biological reaction to toxic chemicals, emulating the biological responses of humans or animals. The biological reaction is converted into an electronic signal that can be read by the user.

"In my lab, we developed a method for communicating with the microbes, converting this biological response to electrical signals," Prof. Shacham-Diamand explained. The device, which looks like a dipstick, immobilizes these specially produced microbes next to the sensing electrodes. Once the microbes come into contact with a questionable substance they produce a chemical signal that is converted to an electrical current by a device that can interpret the signals, producing a binary toxic or not toxic diagnosis.

The new chips are based on genetically modified microbes developed in Prof. Belkin's lab. When the modified microbes are exposed to toxic or poisonous materials, they produce a measurable biochemical reaction, which is converted into to electrical signals.

The Dip Chip is designed to alert the user to overall toxicity. Because the chip measures general toxicity, it will pick up on any and all toxic materials -- even those that have not been discovered or invented. Beyond their ability to find toxic chemicals in the field, these chips can also be put to use in the cosmetics or pharmaceutical industries, said Prof. Shacham-Diamand.

Related Links:
Tel Aviv University's Faculty of Engineering
Institute of Life Sciences at the Hebrew University of Jerusalem



New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sample Transportation System
Tempus1800 Necto
Automated MALDI-TOF MS System
EXS 3000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Original illustration showing how exposure-linked mutation patterns may influence tumor immune visibility (Photo courtesy of Máté Manczinger, HUN-REN Szeged BRC)

Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response

Cancer cells accumulate thousands of genetic mutations, but not all mutations affect tumors in the same way. Some make cancer cells more visible to the immune system, while others allow tumors to evade... Read more

Industry

view channel
Image: The addition of Biocare’s complementary IHC antibody, reagent and instrument portfolio enhances Agilent’s immunohistochemistry offering (Photo courtesy of Biocare Medical)

Agilent Technologies Acquires Pathology Diagnostics Company Biocare Medical

Agilent Technologies (Santa Clara, CA, USA) has entered into a definitive agreement to acquire Biocare Medical (Pacheco, CA, USA), expanding its pathology portfolio through the addition of highly complementary... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.